XML 81 R54.htm IDEA: XBRL DOCUMENT
v3.25.2

Accrued Expenses (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Jun. 30, 2025 | Dec. 31, 2024
Accrued Expenses |  |
Schedule of accrued expenses | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | June 30, | ​ | December 31, | ​
​ |  | 2025 |  | 2024 |
Clinical trial expenses | ​ | $ | 1,730,818 | ​ | $ | 1,135,542 | ​
Other | ​ |  | 1,052,331 | ​ |  | 1,223,797 | ​
Total | ​ | $ | 2,783,149 | ​ | $ | 2,359,339 | ​
​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31,
​ |  | 2024 |  | 2023
Clinical trial expenses | ​ | $ | 1,135,542 | ​ | $ | 1,993,784
Other | ​ |  | 1,223,797 | ​ |  | 424,218
Total | ​ | $ | 2,359,339 | ​ | $ | 2,418,002
​

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration